July 2026
- Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty
- Descending Thoracic Aortic Aneurysm
- Pharmacotherapeutic Decisions in Autism
- The Exam Room as Sanctuary — Caring for Undocumented Patients
- The Symptom Tracker
- Long-Term Survival of Hypoimmune Allogeneic Islets without Immunosuppression
- Condyloma Acuminata of the Urethra
- Preserving Lung Function in Idiopathic Pulmonary Fibrosis
- Contextualizing the Dead Donor Rule in an Era of Voluntary Euthanasia
- Treating Acquired Hypothalamic Obesity
- Measles Inclusion-Body Encephalitis after Allogeneic Stem-Cell Transplantation
- Immediate or Deferred Nonculprit-Lesion PCI
- One Pivotal Trial for FDA Approval — Ending the Two-Trial Dogma
- Nutrition Therapy in Critically Ill Adults
- A Rash and Red Urine
- Case 19-2026: A 68-Year-Old Man with Fatigue, Fever, and Hypoxemia
- Trends and Prevalence of Chronic Kidney Disease in the United States
- Setmelanotide for the Treatment of Acquired Hypothalamic Obesity
- Ensartinib in Resected ALK-Positive Non–Small-Cell Lung Cancer
- Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection
- Colliding Forces — The Aging of the Baby Boom Generation and Contracting Nursing-Home Supply
- For Those Left Behind
- Sparganosis
- Caring for an Aging America — The Looming Crisis of the Long-Term–Care Workforce
- Mandated State-Level Surveillance of Assisted Reproductive Technology — An Emerging Threat in the United States
- Ebola at 50 — Lessons for Outbreak Response and Preparedness
- Retraction: Jayne DRW et al. Avacopan for the Treatment of ANCA-Associated Vasculitis, N Engl J Med 2021;384:599-609.
- Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia
- Clinical Characteristics of Patients Infected with Bundibugyo Virus, DRC 2026
- Bundibugyo Virus Disease in 2026 — Clinical and Public Health Responses
- Long-Acting Treatment and Advanced HIV Disease — Addressing a Public Health Priority
- Products That Pose Health Risks — Can Litigation Protect Us When Government Fails?
- The Social Contract of Bundibugyo Ebola Isolation
- The OMB and the Politicization of Science
- Talquetamab–Daratumumab in Relapsed or Refractory Myeloma
- Clinical Long-Read Genome Sequencing for Rare-Disease Diagnostics
- Lonvoguran Ziclumeran — In Vivo CRISPR Gene Editing in Hereditary Angioedema
- Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock
- Vasopressors or Fluids in Early Septic Shock
- Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease
- Carbocisteine or Hypertonic Saline for Acute Respiratory Failure
- Supporting Access to Reliable Health Information with Public–Private Collaboration
- Conservative Oxygen for Unresponsive Patients after Cardiac Arrest
- Survodutide Once Weekly for the Treatment of Adults with Obesity
- Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
- Finerenone in Persons with Chronic Kidney Disease without Diabetes
- Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica
- Emerging Era for Polymyalgia Rheumatica and GCA — Interleukin-17A Targeting
- Obexelimab for the Treatment of IgG4-Related Disease
- Obexelimab and the Promise of Nondepleting B-Cell Therapy in IgG4-Related Disease